durvalumab,medi1191
astrazeneca
['durva']
great to have worked with the study team including on this phase 1 study of intratumoral il12 with durvalumab 
Professor, Medical Oncology @UCSD; PI @Patel_Lab computational immunopathology; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, irAEs (he/him)